Correction: Combined MEK and ERK inhibition overcomes therapy-mediated pathway reactivation in RAS mutant tumors
PLoS One
.
2018 Jan 25;13(1):e0192059.
doi: 10.1371/journal.pone.0192059.
eCollection 2018.
Authors
Mark Merchant
,
John Moffat
,
Gabriele Schaefer
,
Jocelyn Chan
,
Xi Wang
,
Christine Orr
,
Jason Cheng
,
Thomas Hunsaker
,
Lily Shao
,
Stephanie J Wang
,
Marie-Claire Wagle
,
Eva Lin
,
Peter M Haverty
,
Sheerin Shahidi-Latham
,
Hai Ngu
,
Margaret Solon
,
Jeffrey Eastham-Anderson
,
Hartmut Koeppen
,
Shih-Min A Huang
,
Jacob Schwarz
,
Marcia Belvin
,
Daniel Kirouac
,
Melissa R Junttila
PMID:
29370292
PMCID:
PMC5785022
DOI:
10.1371/journal.pone.0192059
Abstract
[This corrects the article DOI: 10.1371/journal.pone.0185862.].
Publication types
Published Erratum